weight-loss drugs
Scope
Date
~
-
Bio & Pharma
SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...
Jul 15, 2022 (Gmt+09:00)
-
Beauty & Cosmetics
Korea’s Cosmax to shut Ohio plant to cut losses; shares up
Cosmax Inc., a major South Korean original design manufacturer (ODM) for L'Oréal and other global cosmetics giants, plans to shut its loss-ma...
Jul 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
1 in 4 biotech firms struggles with decreasing cash reserves
South Korea’s biotechnology firms – public and private alike – are facing increasingly negative financial conditions. T...
Jun 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Korean games
Netmarble to officially launch Seven Knights Revolution on July 28
Netmarble Corp. is poised to officially launch its latest game Seven Knights Revolution on July 28 in South Korea. The South Korean mobile game...
Jun 16, 2022 (Gmt+09:00)
language -
Supply chain
Industrial losses balloon as Korean trucker strike enters 7th day
South Korea’s manufacturing sector faces ballooning losses across industries as the trucker strike entered its seventh day on Monday, disrupti...
Jun 13, 2022 (Gmt+09:00)
language -
Energy
S&P lowers KEPCO’s stand-alone credit rating to non-investment grade
Standard & Poor's (S&P), an international credit rating agency, has lowered Korea Electric Power Corp.'s stand-alone credit profile to non-i...
May 27, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Earnings
Coupang poised to turn to black after smallest loss in Q1
South Korea’s e-commerce giant Coupang Inc. reported the smallest quarterly loss on strong product commerce business, raising hopes for a turn...
May 13, 2022 (Gmt+09:00)
-
Retail
GS Retail shares tumble as new services widen losses
Shares in South Korea's GS Retail Co. suffered their worst percentage fall in nearly five years on May 6, after the convenience store operator's fir...
May 08, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Shipping & Shipbuilding
Samsung Heavy set for 2023 turnaround after eight years of losses
Samsung Heavy Industries Co., one of South Korea's Big Three shipbuilders, was once on the list of assets its parent Samsung Group wanted to sell to...
Apr 11, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
-
IPOs
Kurly’s mounting losses spark controversy over planned IPO
South Korea’s Kurly Inc. nearly doubled its on-year losses on higher costs last year -- raising market controversy over its listing -- as the ...
Apr 06, 2022 (Gmt+09:00)
-
Corporate strategy
SK Chemicals to invest $1.6 bn in green, biopharmaceutical sectors
South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...
Mar 28, 2022 (Gmt+09:00)
language -
Companies
Bulk of Korean firms to face losses if oil price soars to $150
Seven out of 10 South Korean companies predict they will swing to operating losses if global oil prices soar to $150 a barrel, a survey showed on Su...
Mar 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Foreign exchange
Korean won extends losses as oil hits 14-year high
South Korea’s won currency skidded to a fresh low in nearly two years as oil prices spiked to a 14-year peak with fears of a prolonged war bet...
Mar 07, 2022 (Gmt+09:00)
-
Upcoming IPOs
Korea’s Voronoi in talks with global firms on drug designs
South Korea’s biotechnology startup Voronoi Inc. is in talks with global biomedical companies on drug designs as it aims to expand the busines...
Mar 04, 2022 (Gmt+09:00)
-
Earnings
KEPCO at record loss on fuel costs; wider losses seen in 2022
South Korean power utility KEPCO Co. reported its largest-ever operating loss of nearly 6 trillion won ($5 billion) in 2021, after it froze the elec...
Feb 25, 2022 (Gmt+09:00)
-
Earnings
Hyundai Heavy's KSOE posts $1.1 bn loss in 2021
Korea Shipbuilding & Offshore Engineering Co. (KSOE), under Hyundai Heavy Industries Group, on Monday reported a bigger-than-expected operating ...
Feb 07, 2022 (Gmt+09:00)
-
ETFs
The Korea Economic Daily's index set for ETF market debut
Exchange-traded funds (ETFs) have been solidifying their position in the investment market of Korea for the past years. Individual investors in Sout...
Feb 04, 2022 (Gmt+09:00)
-
Earnings
LG Display turns to black in 2021 after three years
South Korea's LG Display Co. swung to an operating profit in 2021 after two consecutive years of shortfalls, led by a sharp rebound in LCD panel pri...
Jan 27, 2022 (Gmt+09:00)
-
Alternative investments
Aju sells San Jose-based hotel at $63 mn after five years
Aju Hotels & Resorts Co., a hospitality firm under Korean conglomerate Aju Group, has sold its San Jose-based hotel to an affiliate of US hosp...
Jan 25, 2022 (Gmt+09:00)
-
Fraud scandals
Investors prepare loss claim for Osstem's fraud case
Minority investors are preparing to file a class-action lawsuit against Osstem Implant Co., which on Monday revealed itself the victim of the larges...
Jan 06, 2022 (Gmt+09:00)
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
-
E-commerce
Coupang’s share price rebounds as market digests lockup release
Shares of Coupang Inc., widely seen as the South Korean version of global e-commerce giant Amazon.com, are staging a rebound as the market is grad...
Dec 27, 2021 (Gmt+09:00)
-
Pharmaceuticals
HK inno.N’s K-CAB a blockbuster drug with $843 million exports
South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...
Dec 24, 2021 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)